Skip to main content
. 2006 Sep 21;12(35):5651–5657. doi: 10.3748/wjg.v12.i35.5651

Table 2.

Summary of expressions, promoter methylation status and clinical associations of the MAGE-A1 and MAGE-A3 genes in 32 colorectal cancer cell lines and 87 colorectal cancer tissues

% of expression % of hypomethylation
MAGE-A1 MAGE-A3 MAGE-A1 MAGE-A3
Cancer cell lines 59 66 81 81
Cancer tissues NT1 NT 43 77
Normal tissues2 NT NT 2 6
MAGE-A1 hypomethylation MAGE-A3 hypomethylation
+ - P + - P
Location
Proximal 14 (31.1%) 31(68.9%) 34 (75.6%) 11 (24.4%)
Distal 17 (56.7%) 13(43.3%) 0.028 26 (86.7%) 4 (13.3%) 0.239
Sex
Male 17 (30.9%) 38(69.1%) 38 (69.1%) 17 (30.9%)
Female 20 (62.5%) 12(18.4%) 0.004 29 (90.6%) 3 (9.4%) 0.021
1

Not tested;

2

Corresponding normal tissues of cancer tissues; +: Represent hypomethylation of MAGE genes; -: Represent no hypomethylation of MAGE genes.